Showing results (221-230 of 254) with videos related to

Sort By:
Pageof 26
Urologic Oncology|September 17, 2019
Definitive and sustained increase in prostate cancer metastases in the United StatesNeal A Patel, Art Sedrakyan, Fernando Bianco, et al.
Annals of Internal Medicine|May 7, 2014
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling studyJoshua A Roth, Ruth Etzioni, Teresa M Waters, et al.
PLOS Global Public Health|May 12, 2025
Can audit and feedback improve health service readiness and delivery outcomes in a low-resource setting? Effectiveness results of the IDEAs strategy from central MozambiqueAneth Dinis, Orvalho Augusto, Quinhas Fernandes, et al.
The Annals of Applied Statistics|January 11, 2019
ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLSJane M Lange, Roman Gulati, Amy S Leonardson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 7, 2011
What if I don't treat my PSA-detected prostate cancer? Answers from three natural history modelsRoman Gulati, Elisabeth M Wever, Alex Tsodikov, et al.
Statistics in Medicine|May 15, 2014
How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes throughStuart G Baker, Ewoud Schuit, Ewout W Steyerberg, et al.
The Journal of Urology|May 11, 2013
Early detection of prostate cancer: AUA GuidelineH Ballentine Carter, Peter C Albertsen, Michael J Barry, et al.
Pigment Cell & Melanoma Research|August 14, 2023
Melanoma literacy among the general population of three western US statesSancy A Leachman, Emile Latour, Brian Detweiler-Bedell, et al.
Cancer|February 14, 2024
The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillanceJonathan L Wright, Jeannette M Schenk, Roman Gulati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2025
LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSISMatejka Rebolj, Adam R Brentnall, Julia Geppert, et al.
Pageof 26